Subscribe to Newsletter

COVID-19

Business & Regulation Business Practice

Pfizer Fallout

| Stephanie Sutton | 3 min read

The pharma giant’s COVID-19 vaccine saved millions of lives, but the company is quickly falling from grace.

Discovery & Development Advanced Medicine

Video Interview: Phil Vanek on the Importance of Regulatory Harmonization

| Stephanie Sutton

We interviewed Gamma Biosciences’s CTO Phil Vanek to learn more about the current state of the Cell and Gene Industry

Discovery & Development Advanced Medicine

Video: Angela Osborne Discusses the Latest Cell and Gene Industry Trends

| Stephanie Sutton

Check out our latest video interview with Angela Osborne who discusses the latest cell and gene industry trends.

Discovery & Development Formulation

Llamas – and Yeast Display – to the Rescue

| Jamie Irvine | 2 min read

Modified screening process optimizes nanobodies for sustainable COVID-19 treatments derived from llamas.

Discovery & Development Formulation

Barking up the Right Tree

| Jamie Irvine | 2 min read

Researchers use genome mining and bioengineering techniques to develop sustainable saponin-based vaccine adjuvants

Discovery & Development Formulation

Teaching Old Vaccines New Tricks

| Joseph Payne | 8 min read

Why is self-amplifying mRNA gaining more and more attention in the vaccine space?

Business & Regulation Business Practice

A Terrifying Awakening

| Rainer Lichtenberger | 8 min read

What are the lessons we must learn from the COVID-19 pandemic?

Business & Regulation COVID-19

COVID-19: Anti-Vaccine Activists Sue Media Outlets

| Stephanie Sutton | 3 min read

Anti-vaccine activists are suing a number of prominent media outlets, including Reuters, the Washington Post, the BBC, and the Associated Press.

Business & Regulation Trends & Forecasts

Winter is Coming: How the Energy Crisis Will Change Pharma in 2023

| Angus Stewart | 6 min read

In the face of war and the economic fallout of COVID-19, Europe is weathering an energy price storm. What does this mean for medicine makers?

Business & Regulation Marketing

#MemeTeam

| Rob Coker | 4 min read

For any organization, one ill-timed tweet can create enormous backlash.


Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register